Determining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipients

Clinical Transplantation

Volumn 28, Issue 1, 2014, Pages 96-104

  Spivey, Christina A ^a   Chisholm Burns, Marie A ^a   Damadzadeh, Bita ^b   Billheimer, Dean ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Environmental Research Laboratory   (United States)

Author keywords

Graft failure; Immunosuppressant adherence; National data registry; Renal transplant

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HISPANIC; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICATION COMPLIANCE; MIDDLE AGED; PRIORITY JOURNAL; RENAL TRANSPLANT RECIPIENT; RETROSPECTIVE STUDY; SURVIVAL TIME; YOUNG ADULT;

GRAFT FAILURE; IMMUNOSUPPRESSANT ADHERENCE; NATIONAL DATA REGISTRY; RENAL TRANSPLANT;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84892443419     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12283     Document Type: Article

References (40)

1. Dew MA, DiMartini AF, De Vito Dabbs A et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007: 83: 858.
2. Vlaminck H, Maes B, Evers G et al. Prospective study on late consequence subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004: 4: 1509.
3. Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004: 77: 769.
4. Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 2009: 9: 2597.
5. Hilbrands LB, Hoitsma AJ, Koene RAP. Medication compliance after renal transplantation. Transplantation 1995: 60: 914.
6. Chisholm MA, Kwong WJ, Spivey CA. Associations of characteristics of renal transplant recipients with clinicians' perceptions of adherence to immunosuppressant therapy. Transplantation 2007: 84: 1145.
7. Gaston R, Hudson S, War M, Jones R, Macon R. Late renal allograft loss: noncompliance masquerading as chronic rejection. Transplant Proc 1999: 31: 21s.
8. Sellarés J, De Freitas DG, Mengel M et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012: 12: 388.
9. Wu O, Levy AR, Briggs A, Lewis G, Jardine A. Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation 2009: 87: 1330.
10. Takemoto SK, Pinsky PW, Schnitzler MA et al. A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients. Am J Transplant 2007: 7: 2704.
11. Chisholm-Burns M, Pinsky B, Parker G et al. Factors influencing immunosuppressant medication adherence in renal transplant recipients. Clin Transplant 2012: 26: 706.
12. Denhaerynk K, Burkhalter F, Schäfer-Keller P, Steiger J, Bock A, De Geest S. Clinical consequences of non adherence to immunosuppressive medication in kidney transplant patients. Transpl Int 2009: 22: 441.
13. Chisholm MA, Lance CE, Mulloy LL. Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients. Am J Health Syst Pharm 2005: 62: 1775.
14. Denhaerynck K, Steiger J, Bock A et al. Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant 2007: 7: 108.
15. Rosenberger J, Geckova AM, Van Dijk JP et al. Prevalence and characteristics of noncompliant behavior and its risk factors in kidney transplant recipients. Transpl Int 2005: 18: 1072.
16. Kiley DJ, Lam CS, Pollack R. A study of treatment compliance following kidney transplantation. Transplantation 1998: 55: 51.
17. Butkus DE, Meydrech EF, Raju SS. Racial differences in the survival of cadaveric renal allografts: overriding effects of HLA matching socioeconomic factors. N Engl J Med 1992: 327: 840.
18. Frazier P, Davis-Ali S, Dahl K. Correlates of noncompliance among renal transplant recipients. Clin Transplant 1994: 8: 550.
19. Greenstein S, Siegal B. Compliance and noncompliance in patients with functioning renal transplant: a multicenter study. Transplantation 1998: 66: 1718.
20. Chisholm MA, Williamson GM, Lance CE, Mulloy LL. Predicting adherence to immunosuppressant therapy: a prospective analysis of the Theory of Planned Behavior. Nephrol Dial Transplant 2007: 22: 2339.
21. Siegal BR, Greenstein SM. Postrenal transplant compliance from the perspective of the African-Americans, Hispanic-Americans, Anglo-Americans. Adv Ren Replace Ther 1997: 4: 46.
22. Ghods AJ, Nasrollahzadeh D. Noncompliance with immunosuppressive medications after renal transplant. Exp Clin Transplant 2003: 1: 39.
23. Chisholm-Burns MA, Kwong WJ, Mulloy LL, Spivey CA. Nonmodifiable characteristics associated with nonadherence to immunosuppressant therapy in renal transplant recipients. Am J Health Syst Pharm 2008: 65: 1242.
24. United Network for Organ Sharing (UNOS). Data collection. Available at http://www.unos.org/donation/index.php?topic=data_collection. Accessed January 24, 2012.
25. Casey MJ, Meier-Kriesche H-U. Calcineurin inhibitors in kidney transplantation: friend or foe? Curr Opin Nephrol Hypertens 2011: 20: 610.
26. Lee RA, Gabardi S. Current trends in immunosuppressive therapies for renal transplant recipients. Am J Health Syst Pharm 2012: 69: 1961.
27. Chisholm-Burns MA, Spivey CA, Rehfeld R, Zawaideh M, Roe DJ, Gruessner R. Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. Am J Transplant 2009: 9: 2497.
28. Harrell FE Jr. Regression modeling strategies. New York: Springer, 2001.
29. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control 1974: 19: 716.
30. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2011 annual data report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, 2012.
31. Fan P-Y, Ashby VB, Fuller DS et al. Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant 2010: 2: 1090.
32. Eckhoff DE, Young CJ, Gaston RS et al. Racial disparities in renal allograft survival: a public health issue? J Am Coll Surg 2007: 204: 894.
33. Medcalf JF, Andrews PA, Bankart J et al. Poorer graft survival in ethnic minorities: results from a multi-centre UK study of kidney transplant outcomes. Clin Nephrol 2011: 75: 294.
34. Page TF, Woodward RS, Brennan DC. The impact of Medicare's lifetime immunosuppressant coverage on racial disparities in kidney graft survival. Am J Transplant 2012: 12: 1519.
35. Oliver JD 3rd, Neff RT, Leeser DB et al. Influence of race on kidney transplantation in the Department of Defense healthcare system. Am J Nephrol 2009: 29: 327.
36. Higgins RSD, Fishman JA. Disparities in solid organ transplantation for ethnic minorities: facts and solutions. Am J Transplant 2006: 6: 2556.
37. Padiyar A, Hricik DE. Immune factors influencing ethnic disparities in kidney transplantation outcomes. Expert Rev Clin Immunol 2011: 7: 769.
38. Humar A, Denny R, Matas AJ, Najarian JS. Graft and quality of life outcomes in older recipients of a kidney transplant. Exp Clin Transplant 2003: 2: 69.
39. Organ Procurement and Transplantation Network (OPTN). National data. Available at http://optn.transplant.hrsa.gov/latestData/rptData.asp. Accessed July 19, 2012.
40. Partridge AH, Avorn J, Wang PS et al. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 2002: 94: 652.